OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 02, 2017
Forced degradation studies can identify stability problems for drug substance and drug products.
Innovation speeds discovery, drives down costs, and improves productivity.
September 01, 2017
Regulatory outsourcing can result in improved compliance, greater transparency, higher productivity, increased cost-effectiveness, and desired strategic outcomes.
August 22, 2017
CDMO Micro-Sphere is investing CHF 21 million (approximately $21.63 million) into the expansion of its GMP manufacturing capabilities at its Swiss facility.
August 16, 2017
Regenerative thermal oxidation (RTO) has become a common solution to treat volatile organic compounds (VOC) and hazardous air pollutants (HAP) present in the emissions of many pharma production processes. Regenerative thermal oxidation devices used to treat halocarbons should be designed to prevent corrosion. Anguil Environmental Systems explains best practices for addressing potential fail points in the materials of construction when designing process emission handling systems.
August 10, 2017
Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.
August 02, 2017
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Amid contentious debate about “fake news,” peer-review papers offer vital, objective insight.
August 01, 2017
The merger enhances STA’s end-to-end capabilities as a full-service contract development and manufacturing organization.
CMOs must embrace flexibility in their technology decisions and business arrangements.